Search filters

List of works by Michael A Postow

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

scientific article published on 23 March 2020

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer

scientific article published on 7 October 2015

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment

scientific article published on 15 December 2014

An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma

scientific article published on 19 October 2016

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

scientific article (publication date: 20 September 2014)

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

scientific article published on 29 February 2016

CTLA-4 antibodies: new directions, new combinations.

scientific article

Checkpoint blocking antibodies in cancer immunotherapy

scientific article published on 23 October 2013

Checkpoint modulation in melanoma: an update on ipilimumab and future directions

scientific article published on October 2013

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience

scientific article published on 02 August 2013

Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes

scientific article

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

scientific article published on 01 August 2018

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

scientific article (publication date: 2 July 2015)

Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes

scientific article

Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma

scientific article published on 25 July 2013

Current options and future directions in the systemic treatment of metastatic melanoma

scientific article published on January 2014

Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment

scientific article published on 08 April 2016

Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution

scientific article

Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature

scientific article published on 15 October 2019

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article published in March 2015

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. ⬇️

scientific article published on 16 November 2017

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

scientific article

Genetic basis for clinical response to CTLA-4 blockade in melanoma

scientific article (publication date: 4 December 2014)

High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy

scientific article published on 04 October 2019

Immune checkpoint modulation: rational design of combination strategies

scientific article published on 10 January 2015

Immune modulation in cancer with antibodies

scientific article published on 30 October 2013

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

scientific article published on 17 August 2015

Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy

scientific article

Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway

scientific article

Immunologic correlates of the abscopal effect in a patient with melanoma

scientific article (publication date: 8 March 2012)

Immunomodulatory therapy for melanoma: ipilimumab and beyond

scientific article published on March 2013

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts.

scientific article

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement

scientific article published on 20 July 2015

Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications ⬇️

scientific article published on October 4, 2012

Ipilimumab for patients with advanced mucosal melanoma

scientific article

Liver resection and ablation for metastatic melanoma: A single center experience

scientific article published on 12 June 2015

Markers for anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) therapy in melanoma

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center

scientific article

Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management ⬇️

scientific article published on October 1, 2012

Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study

scientific article published on 17 October 2017

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

scientific article (publication date: 21 May 2015)

Nivolumab plus ipilimumab in advanced melanoma

scientific article

On being less tolerant: enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation

scientific article published on March 2015

Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma

scientific article published on 16 June 2015

Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab.

scientific article published on 6 May 2014

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.

scientific article

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)

scientific article published on 21 July 2018

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)

scientific article published on 07 September 2020

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

scientific article published on 19 September 2016

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

scientific article published on 10 June 2016

Reply to N. Lowy et al and to J. Dhanda et al.

scientific article published on 21 March 2016

Safety of Infusing Ipilimumab Over 30 Minutes

scientific article published on 29 June 2015

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

scientific article published on 05 March 2015

TNFα Blockade in Checkpoint Inhibition: The Good, the Bad, or the Ugly?

scientific article published on 26 February 2020

The genetic evolution of treatment-resistant cutaneous, acral and uveal melanomas

scientific article published on 15 December 2020

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

scientific article published on 3 November 2017

Therapeutic Implications of KIT in Melanoma ⬇️

scientific article published on March 1, 2012

Paulina is supported by:

About Paulina

Help